Provider: NIHR Journals Library Content:text/plain; charset="UTF-8" TY - JOUR LB - 1. AU - Mitton, D AU - Ackroyd, R TI - A brief overview of photodynamic therapy in Europe J2 - Photodiagn Photodyn Ther PY - 2008 VL - 5 SP - 103 EP - 111 ER - TY - JOUR LB - 2. AU - Huang, Z TI - A review of progress in clinical photodynamic therapy J2 - Technol Cancer Res Treat PY - 2005 VL - 4 SP - 283 EP - 293 ER - TY - ELEC LB - 3. TI - Leeds Centre for Photobiology and Photodynamic Therapy PY - 2009 UR - www.bmb.leeds.ac.uk/pdt/index.html M1 - 15 July 2009 ER - TY - JOUR LB - 4. AU - Kelty, CJ AU - Brown, NJ AU - Reed, MWR AU - Ackroyd, R TI - The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis J2 - Photochem Photobiol Sci PY - 2002 VL - 1 SP - 158 EP - 168 ER - TY - JOUR LB - 5. AU - Morton, CA AU - Brown, SB AU - Collins, S AU - Ibbotson, S AU - Jenkinson, H AU - Kurwa, H TI - Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group J2 - Br J Dermatol PY - 2002 VL - 146 SP - 552 EP - 567 ER - TY - ELEC LB - 6. AU - National Institute for Health and Clinical Excellence (NICE) TI - Photodynamic therapy for early-stage oesophageal cancer (Interventional Procedure Guidance: IPG200) CY - NICE, London PY - 2006 UR - http://guidance.nice.org.uk/IPG200 ER - TY - ELEC LB - 7. AU - National Institute for Health and Clinical Excellence (NICE) TI - Palliative photodynamic therapy for advanced oesophageal cancer (Interventional Procedure Guidance: IPG206) CY - NICE, London PY - 2007 UR - http://guidance.nice.org.uk/IPG206 ER - TY - ELEC LB - 8. AU - National Institute for Health and Clinical Excellence (NICE) TI - Photodynamic therapy for advanced bronchial carcinoma (Interventional Procedure Guidance: IPG87) CY - NICE, London PY - 2004 UR - www.nice.org.uk/Guidance/IPG087 ER - TY - ELEC LB - 9. AU - National Institute for Health and Clinical Excellence (NICE) TI - Photodynamic therapy for high-grade dysplasia in Barrett’s oesophagus (Interventional Procedure Guidance: IPG82) CY - NICE, London PY - 2004 UR - www.nice.org.uk/Guidance/IPG082 ER - TY - ELEC LB - 10. AU - National Institute for Health and Clinical Excellence (NICE) TI - Photodynamic therapy for bile duct cancer (Interventional Procedure Guidance: IPG134) CY - NICE, London PY - 2005 UR - www.nice.org.uk/Guidance/IPG134 ER - TY - ELEC LB - 11. AU - National Institute for Health and Clinical Excellence (NICE) TI - Photodynamic therapy for localised inoperable endobronchial cancer (Interventional Procedure Guidance: IPG137) CY - NICE, London PY - 2005 UR - www.nice.org.uk/Guidance/IPG137 ER - TY - ELEC LB - 12. AU - National Institute for Health and Clinical Excellence (NICE) TI - Photodynamic therapy for non-melanoma skin tumours (including premalignant and primary non-metastatic skin lesions) (Interventional Procedure Guidance: IPG155) CY - NICE, London PY - 2006 UR - http://guidance.nice.org.uk/IPG155 ER - TY - ELEC LB - 13. AU - National Institute for Health and Clinical Excellence (NICE) TI - Photodynamic therapy for brain tumours (Interventional Procedure Guidance: IPG290) CY - NICE, London PY - 2009 UR - www.nice.org.uk/Guidance/IPG290 ER - TY - ELEC LB - 14. AU - National Institute for Health and Clinical Excellence (NICE) TI - Interstitial photodynamic therapy for malignant parotid tumours (Interventional Procedure Guidance: IPG259) CY - NICE, London PY - 2008 UR - www.nice.org.uk/Guidance/IPG259 ER - TY - ELEC LB - 15. AU - Centre for Reviews and Dissemination (CRD) TI - CRD website help page UR - www.crd.york.ac.uk/crdweb/html/help.htm M1 - 15 July 2009 ER - TY - JOUR LB - 16. AU - Maziak, DE AU - Markman, BR AU - MacKay, JA AU - Evans, WK TI - Photodynamic therapy in nonsmall cell lung cancer: a systematic review J2 - Ann Thorac Surg PY - 2004 VL - 77 SP - 1484 EP - 1491 UR - www.sciencedirect.com/science/article/B6T11–4C283BF-35/2/6d1bff1bcf1847ce68d8a49ded9218d8 ER - TY - RPRT LB - 17. TI - Photodynamic therapy for cancer summaries and evidence tables [unpublished draft report] AU - Edmonton, AB PB - Health Technology and Policy Unit, School of Public Health, University of Alberta ER - TY - BOOK LB - 18. TI - Photodynamic therapy for the treatment of Barrett’s esophagus: a systematic review and economic evaluation AU - Edmonton, AB PB - Health Technology & Policy Unit, School of Public Health, Department of Public Health Sciences, University of Alberta PY - 2009 ER - TY - BOOK LB - 19. TI - Photodynamic therapy for the treatment of early esophageal cancer: a systematic review and economic evaluation AU - Edmonton, AB PB - Health Technology & Policy Unit, School of Public Health, Department of Public Health Sciences, University of Alberta PY - 2009 ER - TY - JOUR LB - 20. AU - Green, S AU - Tawil, A AU - Barr, H AU - Bennett, C AU - Bhandari, P AU - DeCaestecker, J TI - Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett’s oesophagus J2 - Cochrane Database Syst Rev PY - 2009 VL - 2 UR - 10.1002/14651858 ER - TY - JOUR LB - 21. AU - Rees, J AU - Lao-Sireix, P AU - Wong, A AU - Fitzgerald, R TI - Treatment for Barett’s oesophagus J2 - Cochrane Database Syst Rev PY - 2010 VL - 1 ER - TY - GEN LB - 22. AU - Centre for Reviews and Dissemination (CRD) TI - Systematic reviews: CRD’s guidance for undertaking reviews in healthcare ET - 3rd CY - York PB - CRD PY - 2009 ER - TY - JOUR LB - 23. AU - Moher, D AU - Cook, DJ AU - Eastwood, S AU - Olkin, I AU - Rennie, D AU - Stroup, DF TI - Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses J2 - Lancet PY - 1999 VL - 354 SP - 1896 EP - 1900 ER - TY - GEN LB - 24. AU - endnote TI - X1.0.01 Bld 2682 edn CY - New York CY - Thomson Reuters PY - 2009 ER - TY - GEN LB - 25. AU - eppi-reviewer ET - 3.0 CY - London PB - EPPI-Centre, Social Science Research Unit, Institute of Education, University of London PY - 2009 ER - TY - GEN LB - 26. AU - revman ET - 5.0.20 CY - Oxford PB - Cochrane Collaboration PY - 2009 ER - TY - JOUR LB - 27. AU - Marks, R AU - Jolley, D AU - Dorevitch, AP AU - Selwood, TS TI - The incidence of non-melanocytic skin cancers in an Australian population: results of a five-year prospective study J2 - Med J Aust PY - 1989 VL - 150 SP - 475 EP - 478 ER - TY - JOUR LB - 28. AU - Marks, R AU - Selwood, TS TI - Solar keratoses. The association with erythemal ultraviolet radiation in Australia J2 - Cancer PY - 1985 VL - 56 SP - 2332 EP - 2336 ER - TY - JOUR LB - 29. AU - Memon, A AU - Tomenson, J AU - Bothwell, J AU - Freidmann, P TI - Prevalence of solar damage and actinic keratois in a Merseyside population J2 - Br J Dermatol PY - 2000 VL - 142 SP - 1154 EP - 1159 ER - TY - JOUR LB - 30. AU - Lehmann, P TI - Methyl aminolaevulinatephotodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer J2 - Br J Dermatol PY - 2007 VL - 156 SP - 793 EP - 801 UR - www.ingentaconnect.com/content/bsc/bjd/2007/00000156/00000005/art00002 ER - TY - BOOK LB - 31. AU - Helfand, M AU - Gorman, AK AU - Mahon, S AU - Chan, BKS AU - Swanson, N TI - Actinic keratoses CY - Portland, OR PB - Oregon Health & Science University, Evidence Based Practice Centre PY - 2001 ER - TY - JOUR LB - 32. AU - Olsen, EA AU - Abernethy, L AU - Kulp-Shorten, C AU - Callen, JP AU - Glazer, SD AU - Huntley, A TI - A double-blind vehicle controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck J2 - J Am Acad Dermatol PY - 1991 VL - 24 SP - 738 EP - 743 ER - TY - BOOK LB - 33. AU - Hamblin, MR AU - Mroz, P TI - Advances in photodynamic therapy: basic, transitional and clinical CY - Boston PB - Artech House PY - 2008 ER - TY - JOUR LB - 34. AU - Stritt, A AU - Merk, H AU - Braathen, L AU - von Felbert, V TI - Photodynamic therapy in the treatment of actinic keratosis J2 - Photochem Photobiol PY - 2008 VL - 84 SP - 388 EP - 398 ER - TY - JOUR LB - 35. AU - Gupta, AK J2 - J Am Acad Dermatol PY - 2004 VL - 50 SP - P501 ER - TY - JOUR LB - 36. AU - Legat, FJ AU - Holzer, A AU - Wackernagel, A AU - Hofer, A AU - Quehenberger, F AU - Kerl, H TI - Photodynamic therapy (PDT) with fractionated versus unfractionated illumination: a half-side comparison in patients with actinic keratoses J2 - J Invest Dermatol PY - 2006 VL - 126 SP - 77 ER - TY - JOUR LB - 37. AU - Moloney, FJ AU - Collins, P TI - Randomised, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis J2 - J Invest Dermatol PY - 2007 VL - 127 SP - 2692 ER - TY - JOUR LB - 38. AU - Szeimies, M AU - Babilas, P AU - Hummel, S AU - Koller, M AU - Knobler, R TI - Variable pulsed light (VPL) reduces treatment pain in patients undergoing photodynamic therapy (PDT) for actinic keratoses J2 - J Invest Dermatol PY - 2007 VL - 127 SP - 837 ER - TY - JOUR LB - 39. AU - Touma, D AU - Whitehead, S AU - Konnikov, N AU - Phillips, T AU - Yaar, M AU - Gilchrest, B TI - Short incubation delta-ALA PDT for treatment of actinic keratoses and facial photodamage J2 - Lasers Surg Med PY - 2003 VL - 32 SP - 42 ER - TY - JOUR LB - 40. AU - Wiegell, SR AU - Haedersdal, M AU - Wulf, H TI - Photodynamic therapy of actinic keratoses with two different concentrations of methyl aminolevulinate and home-based daylight exposure: a randomized, controlled, double-blinded study [Abstract] J2 - J Invest Dermatol PY - 2008 VL - 128 SP - 1220 ER - TY - JOUR LB - 41. AU - Jeffes, E AU - McCullough, J AU - Weinstein, G AU - Shull, T AU - Kaplan, R AU - Glazer, S TI - Photodynamic therapy of patients having multiple actinic keratoses with topical 5-aminolevulinic acid (ALA) and non-laser blue light [Abstract] J2 - J Invest Dermatol PY - 1998 VL - 110 SP - 680 EP - 1248 ER - TY - JOUR LB - 42. AU - Dragieva, G AU - Prinz, BM AU - Hafner, J AU - Dummer, R AU - Burg, G AU - Binswanger, U TI - A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients J2 - Br J Dermatol PY - 2004 VL - 151 SP - 196 EP - 200 ER - TY - JOUR LB - 43. AU - Ericson, MB AU - Sandberg, C AU - Stenquist, B AU - Gudmundson, F AU - Karlsson, M AU - Ros, AM TI - Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome J2 - Br J Dermatol PY - 2004 VL - 151 SP - 1204 EP - 1212 ER - TY - JOUR LB - 44. AU - Fowler, JF, Jr AU - Zax, RH TI - Aminolevulinic acid hydrochloride with photodynamic therapy: efficacy outcomes and recurrence 4 years after treatment J2 - Cutis PY - 2002 VL - 69 SP - 2 EP - 7 ER - TY - JOUR LB - 45. AU - Freeman, M AU - Vinciullo, C AU - Francis, D AU - Spelman, L AU - Nguyen, R AU - Fergin, P TI - A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study J2 - J Dermatol Treat PY - 2003 VL - 14 SP - 99 EP - 106 ER - TY - JOUR LB - 46. AU - Kaufmann, R AU - Spelman, L AU - Weightman, W AU - Reifenberger, J AU - Szeimies, RM AU - Verhaeghe, E TI - Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities J2 - Br J Dermatol PY - 2008 VL - 158 SP - 994 EP - 999 ER - TY - JOUR LB - 47. AU - Kurwa, HA AU - Yong-Gee, SA AU - Seed, PT AU - Markey, AC AU - Barlow, RJ TI - A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses J2 - J Am Acad Dermatol PY - 1999 VL - 41 SP - 414 EP - 418 ER - TY - JOUR LB - 48. AU - Morton, C AU - Campbell, S AU - Gupta, G AU - Keohane, S AU - Lear, J AU - Zaki, I TI - Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study J2 - Br J Dermatol PY - 2006 VL - 155 SP - 1029 EP - 1036 ER - TY - JOUR LB - 49. AU - Pariser, DM AU - Lowe, NJ AU - Stewart, DM AU - Jarratt, MT AU - Lucky, AW AU - Pariser, RJ TI - Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial J2 - J Am Acad Dermatol PY - 2003 VL - 48 SP - 227 EP - 232 ER - TY - JOUR LB - 50. AU - Smith, S AU - Piacquadio, D AU - Morhenn, V AU - Atkin, D AU - Fitzpatrick, R TI - Short incubation PDT versus 5-FU in treating actinic keratoses J2 - J Drugs Dermatol PY - 2003 VL - 2 SP - 629 EP - 635 ER - TY - JOUR LB - 51. AU - Szeimies, RM AU - Karrer, S AU - Radakovic-Fijan, S AU - Tanew, A AU - Calzavara-Pinton, PG AU - Zane, C TI - Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study J2 - J Am Acad Dermatol PY - 2002 VL - 47 SP - 258 EP - 262 ER - TY - JOUR LB - 52. AU - Tarstedt, M AU - Rosdahl, I AU - Berne, B AU - Svanberg, K AU - Wennberg, A-M TI - A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp J2 - Acta Dermatol Venereol PY - 2005 VL - 85 SP - 424 EP - 428 ER - TY - JOUR LB - 53. AU - Wiegell, SR AU - Haedersdal, M AU - Philipsen, PA AU - Eriksen, P AU - Enk, CD AU - Wulf, HC TI - Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study J2 - Br J Dermatol PY - 2008 VL - 158 SP - 740 EP - 746 ER - TY - JOUR LB - 54. AU - Braathen, LR AU - Paredes, BE AU - Saksela, O AU - Fritsch, C AU - Gardlo, K AU - Morken, T TI - Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses J2 - J Eur Acad Dermatol Venereol PY - 2009 VL - 23 SP - 550 EP - 555 ER - TY - JOUR LB - 55. AU - Hauschild, A AU - Popp, G AU - Stockfleth, E AU - Meyer, K-G AU - Imberger, D AU - Mohr, P TI - Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self-adhesive 5-aminolaevulinic acid patch J2 - Exp Dermatol PY - 2009 VL - 18 SP - 116 EP - 121 ER - TY - JOUR LB - 56. AU - Pariser, D AU - Loss, R AU - Jarratt, M AU - Abramovits, W AU - Spencer, J AU - Geronemus, R TI - Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: a randomized, double-blind, placebo-controlled study J2 - J Am Acad Dermatol PY - 2008 VL - 59 SP - 569 EP - 576 ER - TY - JOUR LB - 57. AU - Puizina-Ivic, N AU - Zorc, H AU - Vanjaka-Rogosic, L AU - Miric, L AU - Persin, A TI - Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy J2 - Coll Antropol PY - 2008 VL - 32 IS - Suppl. 2 SP - 67 EP - 73 ER - TY - JOUR LB - 58. AU - Szeimies, R-M AU - Matheson, RT AU - Davis, SA AU - Bhatia, AC AU - Frambach, Y AU - Klovekorn, W TI - Topical methyl aminolevulinate photodynamic therapy using red light-emitting diode light for multiple actinic keratoses: a randomized study J2 - Dermatol Surg PY - 2009 VL - 35 SP - 586 EP - 592 ER - TY - JOUR LB - 59. AU - Wennberg, A-M AU - Stenquist, B AU - Stockfleth, E AU - Keohane, S AU - Lear, JT AU - Jemec, G TI - Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: a randomized study J2 - Transplantation PY - 2008 VL - 86 SP - 423 EP - 429 ER - TY - JOUR LB - 60. AU - Hauschild, A AU - Stockfleth, E AU - Popp, G AU - Borrosch, F AU - Bruning, H AU - Dominicus, R TI - Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies J2 - Br J Dermatol PY - 2009 VL - 160 SP - 1066 EP - 1074 ER - TY - JOUR LB - 61. AU - Sotiriou, E AU - Apalla, Z AU - Maliamani, F AU - Zaparas, N AU - Panagiotidou, D AU - Ioannides, D TI - Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities J2 - J Eur Acad Dermatol Venereol PY - 2009 VL - 23 SP - 1061 EP - 1065 ER - TY - JOUR LB - 62. AU - Sylvester, RJ AU - Pinedo, HM AU - De Pauw, M AU - Staquet, MJ AU - Buyse, ME AU - Renard, J TI - Quality of institutional participation in multicenter clinical trials J2 - N Engl J Med PY - 1981 VL - 305 SP - 852 EP - 855 ER - TY - JOUR LB - 63. AU - Ioannidis, JP AU - Dixon, DO AU - McIntosh, M AU - Albert, JM AU - Bozzette, SA AU - Schnittman, SM TI - Relationship between event rates and treatment effects in clinical site differences within multicenter trials: an example from primary J2 - Pneumocystis carinii J2 - Control Clin Trials PY - 1999 VL - 20 SP - 253 EP - 266 ER - TY - JOUR LB - 64. AU - Attili, SK AU - Ibbotson, SH TI - How we treat Bowen’s disease with topical photodynamic therapy in Dundee J2 - Photodiagn Photodyn Ther PY - 2009 VL - 6 SP - 41 EP - 45 ER - TY - ELEC LB - 65. AU - Cancerbackup UR - www.cancerbackup.org.uk/Home M1 - 4 June 2009 ER - TY - JOUR LB - 66. AU - Chute, CG AU - Chuang, T-Y AU - Bergstralh, EJ AU - Su, WP TI - The subsequent risk of internal cancer with Bowen’s disease. A population-based study J2 - JAMA PY - 1991 VL - 266 SP - 816 EP - 819 ER - TY - JOUR LB - 67. AU - Cox, NH AU - Eedy, DJ AU - Morton, CA TI - Guidelines for management of Bowen’s disease. British Association of Dermatologists J2 - Br J Dermatol PY - 1999 VL - 141 SP - 633 EP - 641 ER - TY - JOUR LB - 68. AU - Lui, H AU - Hobbs, L AU - Tope, WD AU - Lee, PK AU - Elmets, C AU - Provost, N TI - Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes J2 - Arch Dermatol PY - 2004 VL - 140 SP - 26 EP - 32 ER - TY - JOUR LB - 69. AU - de Haas, ERM AU - Sterenborg, HJCM AU - Neumann, HAM AU - Robinson, DJ TI - Response of Bowen disease to ALA-PDT using a single and a 2-fold illumination scheme J2 - Arch Dermatol PY - 2007 VL - 143 SP - 264 EP - 265 ER - TY - JOUR LB - 70. AU - Morton, CA AU - Whitehurst, C AU - Moore, JV AU - MacKie, RM TI - Comparison of red and green light in the treatment of Bowen’s disease by photodynamic therapy J2 - Br J Dermatol PY - 2000 VL - 143 SP - 767 EP - 772 ER - TY - JOUR LB - 71. AU - Morton, CA AU - Whitehurst, C AU - Moseley, H AU - McColl, JH AU - Moore, JV AU - Mackie, RM TI - Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen’s disease J2 - Br J Dermatol PY - 1996 VL - 135 SP - 766 EP - 771 ER - TY - JOUR LB - 72. AU - Salim, A AU - Leman, JA AU - McColl, JH AU - Chapman, R AU - Morton, CA TI - Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen’s disease J2 - Br J Dermatol PY - 2003 VL - 148 SP - 539 EP - 543 ER - TY - JOUR LB - 73. AU - Morton, C AU - Horn, M AU - Leman, J AU - Tack, B AU - Bedane, C AU - Tjioe, M TI - Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial J2 - Arch Dermatol PY - 2006 VL - 142 SP - 729 EP - 735 ER - TY - JOUR LB - 74. AU - Bath-Hextall, FJ AU - Perkins, W AU - Bong, J AU - Williams, HC TI - Interventions for basal cell carcinoma of the skin J2 - Cochrane Database Syst Rev PY - 2007 VL - 1 ER - TY - JOUR LB - 75. AU - Raasch, BA AU - Buettner, PG TI - Multiple nonmelanoma skin cancer in an exposed Australian population J2 - Int J Dermatol PY - 2002 VL - 41 SP - 652 EP - 658 ER - TY - JOUR LB - 76. AU - Telfer, NR AU - Colver, GB AU - Morton, CA AU - British Association of Dermatologists TI - Guidelines for the management of basal cell carcinoma J2 - Br J Dermatol PY - 2008 VL - 159 SP - 35 EP - 48 ER - TY - JOUR LB - 77. AU - Foley, P AU - Freeman, M AU - Siller, G AU - Gebauer, K AU - Murrell, D AU - Barnetson, R TI - A phase III randomized study comparing photodynamic therapy (PDT) using methyl aminolevulinate or placebo cream in nodular basal cell carcinoma (NBCC) [Abstract P9–14] J2 - J Eur Acad Dermatol Venereol PY - 2003 VL - 17 SP - 231 ER - TY - JOUR LB - 78. AU - Tope, WD AU - Menter, A AU - El-Azhary, RA AU - Lowe, NJ TI - Comparison of topical methylaminolevulinate photodynamic therapy versus placebo photodynamic therapy in nodular basal cell carcinoma J2 - J Am Acad Dermatol PY - 2004 VL - 50 SP - P477 ER - TY - JOUR LB - 79. AU - Basset-Seguin, N AU - Ibbotson, SH AU - Emtestam, L AU - Tarstedt, M AU - Morton, C AU - Maroti, M TI - Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial J2 - Eur J Dermatol PY - 2008 VL - 18 SP - 547 EP - 553 ER - TY - JOUR LB - 80. AU - Szeimies, RM AU - Ibbotson, S AU - Murrell, DF AU - Rubel, D AU - Frambach, Y AU - de Berker, D TI - A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8–20 mm), with a 12-month follow-up J2 - J Eur Acad Dermatol Venereol PY - 2008 VL - 22 SP - 1302 EP - 1311 ER - TY - JOUR LB - 81. AU - Schleier, P AU - Berndt, A AU - Kolossa, S AU - Zenk, W AU - Hyckel, P AU - Schultze-Mosgau, S TI - Comparison of aminolevulinic acid (ALA)-thermogel-PDT with methyl-ALA-thermogel-PDT in basal cell carcinoma J2 - Photodiagn Photodyn Ther PY - 2007 VL - 4 SP - 197 EP - 201 ER - TY - JOUR LB - 82. AU - Soler, AM AU - Angell-Petersen, E AU - Warloe, T AU - Tausjo, J AU - Steen, HB AU - Moan, J TI - Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources J2 - Photochem Photobiol PY - 2000 VL - 71 SP - 724 EP - 729 ER - TY - JOUR LB - 83. AU - de Haas, ERM AU - Kruijt, B AU - Sterenborg, HJCM AU - Martino Neumann, HA AU - Robinson, DJ TI - Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy J2 - J Invest Dermatol PY - 2006 VL - 126 SP - 2679 EP - 2686 ER - TY - JOUR LB - 84. AU - Kuijpers, DI AU - Thissen, MR AU - Thissen, CA AU - Neumann, MH TI - Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma J2 - J Drugs Dermatol PY - 2006 VL - 5 SP - 642 EP - 645 ER - TY - JOUR LB - 85. AU - Rhodes, LE AU - de Rie, MA AU - Leifsdottir, R AU - Yu, RC AU - Bachmann, I AU - Goulden, V TI - Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma J2 - Arch Dermatol PY - 2007 VL - 143 SP - 1131 EP - 1136 ER - TY - JOUR LB - 86. AU - Mosterd, K AU - Thissen, MRTM AU - Nelemans, P AU - Kelleners-Smeets, NWJ AU - Janssen, RLLT AU - Broekhof, KGME TI - Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial J2 - Br J Dermatol PY - 2008 VL - 159 SP - 864 EP - 870 ER - TY - JOUR LB - 87. AU - Berroeta, L AU - Clark, C AU - Dawe, RS AU - Ibbotson, SH AU - Fleming, CJ TI - A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low-risk nodular basal cell carcinoma J2 - Br J Dermatol PY - 2007 VL - 157 SP - 401 EP - 403 ER - TY - JOUR LB - 88. AU - Wang, I AU - Bendsoe, N AU - Klinteberg, CA AU - Enejder, AM AU - Andersson-Engels, S AU - Svanberg, S TI - Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial J2 - Br J Dermatol PY - 2001 VL - 144 SP - 832 EP - 840 ER - TY - JOUR LB - 89. AU - Soga, F AU - Hanada, K AU - Katoh, N AU - Kishimoto, S TI - Successful treatment of oral florid papillomatosis with a combination modality of photodynamic therapy and oral etretinate J2 - Skin Res PY - 2004 VL - 3 SP - 485 EP - 488 ER - TY - JOUR LB - 90. AU - Wolfsen, HC AU - Hemminger, LL AU - Wallace, MB AU - Devault, KR TI - Clinical experience of patients undergoing photodynamic therapy for Barrett’s dysplasia or cancer J2 - Aliment Pharmacol Ther PY - 2004 VL - 20 SP - 1125 EP - 1131 ER - TY - JOUR LB - 91. AU - Mesquita, A AU - Sa, F AU - Issa, MC AU - Villar, E TI - Photodynamic therapy with methyl aminolevulinate and LED (red light) to nodular basal cell carcinoma in the leg J2 - J Am Acad Dermatol PY - 2007 VL - 56 SP - A165 ER - TY - JOUR LB - 92. AU - Soler, AM AU - Warloe, T AU - Berner, A AU - Giercksky, KE TI - A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage J2 - Br J Dermatol PY - 2001 VL - 145 SP - 467 EP - 471 ER - TY - ELEC LB - 93. TI - Barrett’s Esophagus website UR - www.barrettsinfo.com/ M1 - 7 July 2009 ER - TY - JOUR LB - 94. AU - Gray, J AU - Fullarton, G TI - The current role of photodynamic therapy in oesophageal dysplasia and cancer J2 - Photodiagn Photodyn Ther PY - 2007 VL - 4 SP - 151 EP - 159 ER - TY - JOUR LB - 95. AU - Ackroyd, R AU - Brown, NJ AU - Davis, MF AU - Stephenson, TJ AU - Marcus, SL AU - Stoddard, CJ TI - Photodynamic therapy for dysplastic Barrett’s oesophagus: a prospective, double blind, randomised, placebo controlled trial J2 - Gut PY - 2000 VL - 47 SP - 612 EP - 617 ER - TY - JOUR LB - 96. AU - Ackroyd, R AU - Brown, N AU - Reed, MWR TI - Photodynamic therapy (PDT) for Barrett’s oesophagus: establishing optimal treatment parameters [Abstract] J2 - Eur J Surg Oncol PY - 1996 VL - 22 SP - 551 EP - 552 ER - TY - JOUR LB - 97. AU - Hage, M AU - Siersema, PD AU - van Dekken, H AU - Steyerberg, EW AU - Haringsma, J AU - van de Vrie, W J2 - 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett’s oesophagus: a randomised trial J2 - Gut PY - 2004 VL - 53 SP - 785 EP - 790 ER - TY - JOUR LB - 98. AU - Kelty, CJ AU - Ackroyd, R AU - Brown, NJ AU - Stephenson, TJ AU - Stoddard, CJ AU - Reed, MWR TI - Endoscopic ablation of Barrett’s oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation J2 - Aliment Pharmacol Ther PY - 2004 VL - 20 SP - 1289 EP - 1296 ER - TY - JOUR LB - 99. AU - Overholt, BF AU - Wang, KK AU - Burdick, JS AU - Lightdale, CJ AU - Kimmey, M AU - Nava, HR TI - Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett’s high-grade dysplasia J2 - Gastrointest Endosc PY - 2007 VL - 66 SP - 460 EP - 468 ER - TY - JOUR LB - 100. AU - Ragunath, K AU - Krasner, N AU - Raman, VS AU - Haqqani, MT AU - Phillips, CJ AU - Cheung, I TI - Endoscopic ablation of dysplastic Barrett’s oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness J2 - Scand J Gastroenterol PY - 2005 VL - 40 SP - 750 EP - 758 ER - TY - JOUR LB - 101. AU - Zoepf, T AU - Alsenbesy, M AU - Jakobs, R AU - Apel, D AU - Rosenbaum, A AU - Riemann, JF TI - Photodynamic therapy (PDT) versus argon plasma, coagulation (APC) for ablative therapy of Barrett’s esophagus J2 - Gastrointest Endosc PY - 2003 VL - 57 SP - A139 ER - TY - JOUR LB - 102. AU - Kelty, CJ AU - Ackroyd, R AU - Brown, NJ AU - Brown, SB AU - Reed, MWR TI - Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett’s esophagus J2 - Surg Endosc PY - 2004 VL - 18 SP - 452 EP - 458 ER - TY - JOUR LB - 103. AU - Mackenzie, G AU - Selvasekar, C AU - Jamieson, N AU - Mosse, C AU - Thorpe, S AU - Novelli, M TI - Low incidence of esophageal adenocarcinoma following optimal regimen of ALA PDT for high grade dysplasia in Barrett’s esophagus J2 - Gastrointest Endosc PY - 2007 VL - 65 SP - A132 ER - TY - JOUR LB - 104. AU - Mackenzie, GD AU - Dunn, JM AU - Novelli, MR AU - Mosse, S AU - Thorpe, SM AU - Bown, SG TI - Preliminary results of a randomised controlled trial into the safety and efficacy of ala versus photofrin photodynamic therapy for high grade dysplasia in Barrett’s oesophagus J2 - Gut PY - 2008 VL - 57 SP - 34 ER - TY - JOUR LB - 105. AU - Mackenzie, GD AU - Dunn, JM AU - Selvasekar, CR AU - Mosse, CA AU - Thorpe, SM AU - Novelli, MR TI - Optimal conditions for successful ablation of high-grade dysplasia in Barrett’s oesophagus using aminolaevulinic acid photodynamic therapy J2 - Lasers Med Sci PY - 2009 VL - 24 SP - 729 EP - 734 ER - TY - ELEC LB - 106. TI - Cancer Research UK website UR - www.cancerresearchuk.org/ M1 - 2 July 2009 ER - TY - JOUR LB - 107. AU - Canto, MI AU - Gress, F AU - Wolfsen, HC TI - Long term outcomes of curative bare fiber porfimer sodium (Ps): Photodynamic therapy (PDT) for T1NO cancers (CA) of the esophagus and esophagogastric junction (EGJ): a multicenter prospective cohort study J2 - Gastrointest Endosc PY - 2005 VL - 61 SP - A128 ER - TY - JOUR LB - 108. AU - Grosjean, P AU - Wagnieres, G AU - Fontolliet, C AU - van den Bergh, H AU - Monnier, P TI - Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II J2 - Br J Cancer PY - 1998 VL - 77 SP - 1989 EP - 1995 ER - TY - JOUR LB - 109. AU - Savary, JF AU - Grosjean, P AU - Monnier, P AU - Fontolliet, C AU - Wagnieres, G AU - Braichotte, D TI - Photodynamic therapy of early squamous cell carcinomas of the esophagus: a review of 31 cases J2 - Endoscopy PY - 1998 VL - 30 SP - 258 EP - 265 ER - TY - JOUR LB - 110. AU - Scotiniotis, IA AU - Kochman, ML AU - Sanfilipo, N AU - Hahn, S AU - Rosato, E AU - Ginsberg, GG TI - Management of superficial esophageal cancer: outcomes of esophagectomy, photodynamic therapy, or endoscopic mucosal resection J2 - Gastrointest Endosc PY - 2000 VL - 51 SP - 4912 ER - TY - JOUR LB - 111. AU - Lecleire, S AU - Di Fiore, F AU - Antonietti, M AU - Ben-Soussan, E AU - Lerebours, E AU - Michel, P TI - Photodynamic therapy in superficial esophageal cancer: a comparison between patients treated in primary intent and patients treated as a salvage therapy after local failure of chemoradiotherapy J2 - Gastrointest Endosc PY - 2008 VL - 67 SP - A186 EP - AAB7 ER - TY - JOUR LB - 112. AU - Lightdale, CJ AU - Heier, SK AU - Marcon, NE AU - McCaughan, JS, Jr AU - Gerdes, H AU - Overholt, BF TI - Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial J2 - Gastrointest Endosc PY - 1995 VL - 42 SP - 507 EP - 512 ER - TY - JOUR LB - 113. AU - Zhang, NZ AU - Zhu, Y AU - Pan, W AU - Ma, WQ AU - Shao, AL TI - Photodynamic therapy combined with local chemotherapy for the treatment of advanced esophagocardiac carcinoma J2 - Photodiagn Photodyn Ther PY - 2007 VL - 4 SP - 60 EP - 64 ER - TY - JOUR LB - 114. AU - Heier, SK AU - Rothman, KA AU - Heier, LM AU - Rosenthal, WS TI - Photodynamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Nd:YAG laser therapy J2 - Gastroenterology PY - 1995 VL - 109 SP - 63 EP - 72 ER - TY - JOUR LB - 115. AU - Maier, A AU - Anegg, U AU - Fell, B AU - Rehak, P AU - Ratzenhofer, B AU - Tomaselli, F TI - Hyperbaric oxygen and photodynamic therapy in the treatment of advanced carcinoma of the cardia and the esophagus J2 - Lasers Surg Med PY - 2000 VL - 26 SP - 308 EP - 315 ER - TY - JOUR LB - 116. AU - Maier, A AU - Tomaselli, F AU - Anegg, U AU - Rehak, P AU - Fell, B AU - Luznik, S TI - Combined photodynamic therapy and hyperbaric oxygenation in carcinoma of the esophagus and the esophago-gastric junction J2 - Eur J Cardiothorac Surg PY - 2000 VL - 18 SP - 649 EP - 654 ER - TY - JOUR LB - 117. AU - Maier, A AU - Tomaselli, F AU - Gebhard, F AU - Rehak, P AU - Smolle, J AU - Smolle-Juttner, FM TI - Palliation of advanced esophageal carcinoma by photodynamic therapy and irradiation J2 - Ann Thorac Surg PY - 2000 VL - 69 SP - 1006 EP - 1009 ER - TY - JOUR LB - 118. AU - Maier, A AU - Tomaselli, F AU - Matzi, V AU - Rehak, P AU - Pinter, H AU - Smolle-Juttner, FM TI - Does new photosensitizer improve photodynamic therapy in advanced esophageal carcinoma? J2 - Lasers Surg Med PY - 2001 VL - 29 SP - 323 EP - 327 ER - TY - JOUR LB - 119. AU - Zhang, JW AU - Wang, JH AU - Liu, FW TI - Analysis of long term survival rate on radiotherapy combined with photodynamic therapy for advanced esophageal cancer J2 - Zhong Guo Yi Shi Za Zhi PY - 2003 VL - 5 SP - 1058 EP - 1060 ER - TY - JOUR LB - 120. AU - Maier, A AU - Tomaselli, F AU - Matzi, V AU - Rehak, P AU - Pinter, H AU - Smolle-Juttner, FM TI - Photosensitization with hematoporphyrin derivative compared to 5-aminolaevulinic acid for photodynamic therapy of esophageal carcinoma J2 - Ann Thorac Surg PY - 2001 VL - 72 SP - 1136 EP - 1140 ER - TY - JOUR LB - 121. AU - Baas, P AU - Brapho Study Group TI - Photodynamic therapy and/or endobronchial irradiation as pretreatment in external radiation therapy for patients with inoperable non-small cell lung cancer: an interim analysis [Abstract 162] J2 - Eur J Cancer Clin Oncol PY - 1994 VL - 30A SP - 533 ER - TY - JOUR LB - 122. AU - Diaz-Jimenez, JP AU - Martinez-Ballarin, JE AU - Llunell, A AU - Farrero, E AU - Rodriguez, A AU - Castro, MJ TI - Efficacy and safety of photodynamic therapy versus Nd-YAG laser resection in NSCLC with airway obstruction J2 - Eur Respir J PY - 1999 VL - 14 SP - 800 EP - 805 ER - TY - JOUR LB - 123. AU - Lam, S AU - Grafton, C AU - Coy, P AU - Voss, N AU - Fairey, R TI - Combined photodynamic therapy (PDT) using photofrin and radiotherapy (XRT) versus radiotherapy alone in patients with inoperable obstructive nonsmall cell bronchogenic carcinoma J2 - SPIE PY - 1991 VL - 1616 SP - 20 EP - 28 ER - TY - JOUR LB - 124. AU - Lam, S AU - Kostashuk, EC AU - Coy, EP AU - Laukkanen, E AU - LeRiche, JC AU - Mueller, HA TI - A randomized comparative study of the safety and efficacy of photodynamic therapy using Photofrin II combined with palliative radiotherapy versus palliative radiotherapy alone in patients with inoperable obstructive non-small cell bronchogenic carcinoma J2 - Photochem Photobiol PY - 1987 VL - 46 SP - 893 EP - 897 ER - TY - JOUR LB - 125. AU - Leroy, M AU - Diaz-Jimenez, JP AU - Moghissi, K AU - Diaz-Agero, P AU - Spinelli, P AU - Häussiger, K TI - A phase III randomized, comparative trial of photodynamic therapy (PDT) utilising Photofrin r versus thermal ablation therapy using the Nd:YAG laser for obstructing endobronchial lung cancer J2 - Ann Oncol PY - 1998 VL - 9 SP - 83 ER - TY - JOUR LB - 126. AU - Moghissi, K AU - Dixon, K AU - Parsons, RJ TI - A controlled trial of Nd-YAG laser vs photodynamic therapy for advanced malignant bronchial obstruction J2 - Lasers Med Sci PY - 1993 VL - 8 SP - 269 EP - 273 ER - TY - JOUR LB - 127. AU - Maier, A AU - Tomaselli, F AU - Matzi, V AU - Woltsche, M AU - Anegg, U AU - Fell, B TI - Comparison of 5-aminolaevulinic acid and porphyrin photosensitization for photodynamic therapy of malignant bronchial stenosis: a clinical pilot study J2 - Lasers Surg Med PY - 2002 VL - 30 SP - 12 EP - 17 ER - TY - EDBOOK LB - 128. AU - Spin, HG AU - Huber, RM AU - Janes, SM TI - Thoracic malignancies CY - Lausanne PB - European Respiratory Society PY - 2009 ER - TY - JOUR LB - 129. AU - Alijiffry, M AU - Abdulelah, A AU - Walsh, M AU - Peltekian, K AU - Alwayn, I AU - Molinari, M TI - Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature J2 - J Am Coll Surg PY - 2009 VL - 208 SP - 134 EP - 147 ER - TY - JOUR LB - 130. AU - Kiesslich, T AU - Wolkersdorfer, G AU - Neureiter, D AU - Salmhofer, H AU - Berr, F TI - Photodynamic therapy for non-resectable perihilar cholangiocarcinoma J2 - Photochem Photobiol Sci PY - 2009 VL - 8 SP - 23 EP - 30 ER - TY - ELEC LB - 131. TI - The Cholangiocarcinoma Foundation website UR - www.cholangiocarcinoma.org/ M1 - 24 June 2009 ER - TY - JOUR LB - 132. AU - Dechene, A AU - Hildgard, P AU - Maldonado-Lopez, EJ AU - Riemann, JF AU - Gerken, G AU - Zoepf, T TI - Survival difference in patients with photodynamic therapy of nonresectable bile duct cancer using different hematoporphyrins J2 - Gastrointest Endosc PY - 2007 VL - 65 SP - A227 ER - TY - JOUR LB - 133. AU - Kahaleh, M AU - Mishra, R AU - Shami, VM AU - Northup, PG AU - Berg, CL AU - Bashlor, P TI - Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy J2 - Clin Gastroenterol Hepatol PY - 2008 VL - 6 SP - 290 EP - 297 ER - TY - JOUR LB - 134. AU - Ortner, MEJ AU - Caca, K AU - Berr, F AU - Liebetruth, J AU - Mansmann, U AU - Huster, D TI - Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study J2 - Gastroenterology PY - 2003 VL - 125 SP - 1355 EP - 1363 ER - TY - JOUR LB - 135. AU - Witzigmann, H AU - Berr, F AU - Ringel, U AU - Caca, K AU - Uhlmann, D AU - Schoppmeyer, K TI - Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection J2 - Ann Surg PY - 2006 VL - 244 SP - 230 EP - 239 ER - TY - JOUR LB - 136. AU - Zoepf, T AU - Jakobs, R AU - Arnold, JC AU - Apel, D AU - Riemann, JF TI - Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy J2 - Am J Gastroenterol PY - 2005 VL - 100 SP - 2426 EP - 2430 ER - TY - JOUR LB - 137. AU - Gores, GJ TI - A spotlight on cholangiocarcinoma J2 - Gastroenterology PY - 2003 VL - 125 SP - 1536 EP - 1538 ER - TY - JOUR LB - 138. AU - Krishnamurthy, S AU - Powers, SK AU - Witmer, P AU - Brown, T TI - Optimal light dose for interstitial photodynamic therapy in treatment for malignant brain tumors J2 - Lasers Surg Med PY - 2000 VL - 27 SP - 224 EP - 234 ER - TY - JOUR LB - 139. AU - Eljamel, MS AU - Goodman, C AU - Moseley, H TI - ALA and Photofrin(R) Fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial J2 - Lasers Med Sci PY - 2008 VL - 23 SP - 361 EP - 367 ER - TY - JOUR LB - 140. AU - Muller, P AU - Wilson, B AU - Lilge, L AU - Yang, V AU - Varma, A AU - Bogaars, A TI - Clinical studies of photodynamic therapy for malignant brain tumors: Karnofsky score and neurological score in patients with recurrent gloms treated with Photofrin-PDT J2 - SPIE PY - 2002 VL - 4612 SP - 40 EP - 47 ER - TY - JOUR LB - 141. AU - Li, LB AU - Luo, RC AU - Liao, WJ AU - Zhang, MJ AU - Luo, YL AU - Miao, JX TI - Clinical study of Photofrin photodynamic therapy for the treatment of relapse nasopharyngeal carcinoma J2 - Photodiagn Photodyn Ther PY - 2006 VL - 3 SP - 266 EP - 271 ER - TY - JOUR LB - 142. AU - Loukatch, E AU - Latyshevska, G AU - Fekeshgazi, I TI - Intraoperative photodynamic therapy for larynx carcinomas J2 - SPIE PY - 1995 VL - 2395 SP - 245 EP - 246 ER - TY - JOUR LB - 143. AU - Loukatch, E AU - Trojan, V AU - Loukatch, V TI - Intraoperative photodynamic therapy in laryngeal part of pharynx cancers J2 - SPIE PY - 1996 VL - 2924 SP - 305 EP - 308 ER - TY - JOUR LB - 144. AU - Vakulovskaya, E TI - Photodynamic therapy in oral cancer patients with second-generation photosensitizers (P276) J2 - Oral Oncol PY - 2007 VL - 2 IS - Suppl. SP - 215 ER - TY - JOUR LB - 145. AU - Allison, RR AU - Sibata, C AU - Gay, H TI - PDT for cancers of the head and neck J2 - Photodiagn Photodyn Ther PY - 2009 VL - 6 SP - 1 EP - 2 ER - TY - JOUR LB - 146. AU - Bouchie, A TI - In brief: Scotia’s woes J2 - Nat Biotechnol PY - 2001 VL - 19 SP - 189 ER - TY - JOUR LB - 147. AU - Sharpe, D TI - Of apples and oranges, file drawers and garbage: why validity issues in meta-analysis will not go away J2 - Clin Psychol Rev PY - 1997 VL - 17 SP - 881 EP - 901 ER - TY - JOUR LB - 148. AU - Fayter, D AU - McDaid, C AU - Eastwood, A TI - A systematic review highlights threats to validity in studies of barriers to cancer trial participation J2 - J Clin Epidemiol PY - 2007 VL - 60 SP - 990 EP - 1001 ER - TY - JOUR LB - 149. AU - Takuhiro, Y AU - Yasuo, O TI - Investigating centre effects in a multi-centre clinical trial of superficial bladder cancer J2 - Stat Med PY - 1999 VL - 18 SP - 1961 EP - 1971 ER - TY - JOUR LB - 150. AU - Hewitt, C AU - Hahn, S AU - Torgerson, DJ AU - Watson, J AU - Bland, JM TI - Adequacy and reporting of allocation concealment: review of recent trials published in four general medical journals J2 - BMJ PY - 2005 VL - 330 SP - 1057 EP - 1058 ER - TY - JOUR LB - 151. AU - Dumville, JC AU - Torgerson, DJ AU - Hewitt, CE TI - Reporting attrition in randomised controlled trials J2 - BMJ PY - 2006 VL - 332 SP - 969 EP - 971 ER - TY - JOUR LB - 152. AU - Huwiler-Muntener, K AU - Juni, P AU - Junker, C AU - Egger, M TI - Quality of Reporting of Randomized Trials as a Measure of Methodologic Quality J2 - JAMA PY - 2002 VL - 287 SP - 2801 EP - 2804 ER - TY - JOUR LB - 153. AU - Milgrom, LR TI - Towards recombinant antibody-fragment targeted photodynamic therapy J2 - Sci Prog PY - 2008 VL - 91 SP - 241 EP - 263 ER - TY - JOUR LB - 154. AU - Theodossiou, T AU - Hothersall, JS AU - Woods, EA AU - Okkenhaug, K AU - Jacobson, J AU - MacRobert, AJ TI - Firefly Luciferin-activated Rose Bengal: In Vitro Photodynamic Therapy by Intracellular Chemiluminescence in Transgenic NIH 3T3 Cells J2 - Cancer Res PY - 2003 VL - 63 SP - 1818 EP - 1821 ER - TY - JOUR LB - 155. AU - Goodell, T TI - Measuring subjective side effects and symptoms in palliative photodynamic therapy J2 - Oncol Nurs Forum PY - 2006 VL - 33 SP - 647 EP - 650 ER - TY - JOUR LB - 156. AU - Walker, G AU - Andrew Maiden, J TI - Understanding patients’ lived experience following photodynamic therapy for the treatment of advanced cancer J2 - Int J Palliat Nurs PY - 2009 VL - 15 SP - 80 EP - 85 ER - TY - JOUR LB - 157. AU - Donovan, J AU - Mills, N AU - Smith, M AU - Brindle, L AU - Jacoby, A AU - Peters, T TI - Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study * Commentary: presenting unbiased information to patients can be difficult J2 - BMJ PY - 2002 VL - 325 SP - 766 EP - 770 ER - TY - JOUR LB - 158. AU - Schag, CC AU - Heinrich, RL AU - Ganz, PA TI - Karnofsky performance status revisited: reliability, validity, and guidelines J2 - J Clin Oncol PY - 1984 VL - 2 SP - 187 EP - 193 ER - TY - ELEC LB - 159. AU - American Joint Committee on Cancer (AJCC) TI - What is cancer staging? UR - www.cancerstaging.org/mission/whatis.html M1 - 23 July 2009 ER - TY - JOUR LB - 160. AU - Fitzpatrick, TB TI - The validity and practicality of sun-reactive skin types I through VI J2 - Arch Dermatol PY - 1998 VL - 124 SP - 869 EP - 871 ER - TY - JOUR LB - 161. AU - Dragieva, G AU - Prinz, B AU - Hafner, J AU - Dummer, R AU - Burg, G AU - Binswanger, U TI - Topical photodynamic therapy with MAL in the treatment of actinic keratoses in transplant recipients J2 - Br J Dermatol PY - 2005 VL - 153 SP - 97 ER - TY - ELEC LB - 162. TI - Drugs Information Online, 2006 TI - Levulan Kerastick official FDA information, side effects and uses UR - www.drugs.com/pro/levulan-kerastick.html M1 - 19 June 2009 ER - TY - JOUR LB - 163. AU - Piacquadio, DJ AU - Chen, DM AU - Farber, HF AU - Fowler, JF, Jr AU - Glazer, SD AU - Goodman, JJ TI - Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials J2 - Arch Dermatol PY - 2004 VL - 140 SP - 41 EP - 46 ER - TY - JOUR LB - 164. AU - Foley, P AU - Freeman, M AU - Vinciullo, C AU - Spelman, L AU - Murrell, D AU - Weightman, W TI - A comparison of photodynamic therapy using methyl aminolaevulinate with cryotherapy in actinic keratosis [Abstract] J2 - Br J Dermatol PY - 2003 VL - 149 SP - 46 ER - TY - JOUR LB - 165. AU - Foley, P AU - Freeman, M AU - Vinciullo, C AU - Spelman, L AU - Murrell, D AU - Weightman, W TI - Photodynamic therapy using methyl aminolaevulinate with cryotherapy in actinic keratosis: an Australian study [Abstract] J2 - Br J Dermatol PY - 2005 VL - 153 SP - 29 ER - TY - JOUR LB - 166. AU - Hauschild, A AU - Stockfleth, E AU - Popp, G AU - Borrosch, F AU - Bruening, H AU - Dominicus, R TI - Excellent cosmetic outcome after photodynamic therapy of actinic keratosis with an innovative 5-aminolaevulinic acid patch proves superior to cryosurgery J2 - Br J Dermatol PY - 2008 VL - 159 SP - 63 ER - TY - JOUR LB - 167. AU - Morton, C AU - Campbell, S AU - Gupta, G AU - Keohane, S AU - Lear, J AU - Zaki, I TI - Intra-individual comparison of MAL-PDT and cryotherapy in subjects with actinic keratoses: a multicentre, randomized, controlled study J2 - J Invest Dermatol PY - 2006 VL - 126 SP - S33 ER - TY - JOUR LB - 168. AU - Morton, CA AU - Campbell, S AU - Gupta, G AU - Keohane, S AU - Lear, J AU - Walton, S TI - Intra-individual, right-left comparison of methyl aminolaevulinate photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized, controlled study J2 - Br J Dermatol PY - 2006 VL - 155 SP - 122 ER - TY - JOUR LB - 169. AU - Pariser, D AU - Szeimies, RM TI - Results from two randomized, multicenter, vehicle-controlled studies evaluating the efficacy and safety of methyl aminolevulinate-photodynamic therapy for the treatment of actinic keratoses J2 - J Am Acad Dermatol PY - 2008 VL - 58 SP - A105 ER - TY - JOUR LB - 170. AU - Szeimies, R AU - Babilas, P AU - Hummel, S AU - Koller, M AU - Knobler, R TI - Variable pulsed light (VPL) reduces treatment-induced pain in patients undergoing photodynamic therapy for actinic keratoses J2 - J Invest Dermatol PY - 2006 VL - 126 SP - 22 ER - TY - JOUR LB - 171. AU - Szeimies, R AU - Hummel, S AU - Knobler, R TI - Variable pulsed light (VPL) reduces treatment induced pain in patients undergoing photodynamic therapy for actinic keratosis J2 - Exp Dermatol PY - 2007 VL - 16 SP - 249 ER - TY - JOUR LB - 172. AU - Szeimies, RM AU - Banilas, P AU - Hummel, S AU - Koller, M AU - Knobler, R TI - Variable pulsed light (VPL) reduces treatment induced pain in patients undergoing photodynamic therapy for actinic keratosis J2 - J Invest Dermatol PY - 2006 VL - 126 SP - 76 ER - TY - JOUR LB - 173. AU - Babilas, P AU - Knobler, R AU - Hummel, S AU - Gottschaller, C AU - Maisch, T AU - Koller, M TI - Variable pulsed light less painful than light emitting diodes for topical photodynamic therapy of actinic keratoses: a prospective randomized controlled trial J2 - Exp Dermatol PY - 2007 VL - 16 SP - 247 ER - TY - JOUR LB - 174. AU - Szeimies, RM AU - Karrer, S AU - Radakovic-Fijan, S AU - Tanew, A TI - Photodynamic therapy using topical methyl aminolevulinate (MAL-PDT) compared with cryotherapy for actinic keratosis: a European prospective, randomized study J2 - J Am Acad Dermatol PY - 2005 VL - 52 SP - P164 ER - TY - JOUR LB - 175. AU - Szeimies, RM AU - Karrer, S AU - Radakovic-Fijan, S AU - Tanew, A AU - Calzavara-Pinton, PG AU - Zane, C TI - Photodynamic therapy using topical methyl aminolaevulinate photodynamic therapy compared with cryotherapy for actinic keratosis: a European prospective, randomized study J2 - Br J Dermatol PY - 2005 VL - 153 SP - 30 ER - TY - JOUR LB - 176. AU - Wennberg, AM TI - Results from a 15-month update of a multicentre study of methyl aminolaevulinate photodynamic therapy in immunocompromised organ transplant recipients with nonmelanoma skin cancer [Abstract P-79] J2 - Br J Dermatol PY - 2006 VL - 155 SP - 57 ER - TY - JOUR LB - 177. AU - Wennberg, AM AU - Keohane, S AU - Lear, JT AU - Jemec, G AU - Mørk, C AU - Christensen, E TI - A multicenter study of MAL-PDT in immunocompromised organ transplant recipients with non-melanoma skin cancer [Abstract P08.77] J2 - J Eur Acad Dermatol Venereol PY - 2005 VL - 19 SP - 239 ER - TY - CONF LB - 178. AU - Lear, JT AU - Wennberg, AM AU - Schmook, T AU - Keohane, S AU - Stenquist, B AU - Jemec, G TI - A multicenter, study of photodynamic therapy with methyl aminolevulinate (MAL-PDT) in immunocompromised organ transplant recipients with non-melanoma skin cancer T2 - Proceedings of the 15th Congress of the European Academy of Dermatology and Venereology CY - Rhodes, Greece DA - 2006 SP - 677 ER - TY - JOUR LB - 179. AU - Morton, CA TI - Topical photodynamic therapy for Bowen’s disease and basal cell carcinoma: an effective therapy? [Abstract] J2 - Br J Dermatol PY - 1996 VL - 135 SP - 22 ER - TY - JOUR LB - 180. AU - Morton, C TI - Topical photodynamic therapy for Bowen’s disease J2 - Australas J Dermatol PY - 2005 VL - 46 SP - S11 ER - TY - JOUR LB - 181. AU - Morton, CA AU - Horn, M AU - Leman, J AU - Tack, B AU - Bedane, C AU - Tijioe, M TI - A placebo-controlled multicentre study comparing photodynamic therapy using methyl aminolaevulinate with cryotherapy and 5-fluorouracil in Bowen’s disease J2 - Br J Dermatol PY - 2004 VL - 151 SP - 2 ER - TY - JOUR LB - 182. AU - Morton, CA AU - Horn, M AU - Leman, J AU - Tack, B AU - Bedane, C AU - Tjioe, M TI - A randomised, placebo-controlled, European study comparing MAL-PDT with cryotherapy and 5-fluorouracil in subjects with Bowen’s disease J2 - J Invest Dermatol PY - 2006 VL - 126 SP - S36 ER - TY - JOUR LB - 183. AU - Morton, C AU - Horn, M AU - Leman, J AU - Tack, B TI - A placebo-controlled European study comparing MAL-PDT with cryotherapy and 5-fluorouracil in patients with Bowen’s disease J2 - J Am Acad Dermatol PY - 2005 VL - 52 SP - P158 ER - TY - JOUR LB - 184. AU - Morton, C AU - Horn, M AU - Leman, J AU - Tack, B AU - Bedane, C AU - Tjioe, M TI - A placebo controlled European study controlling methylaminolaevulinate photodynamic therapy with cryotherapy and 5-fluorocaril in patients with Bowen’s disease J2 - Br J Dermatol PY - 2005 VL - 153 SP - 30 ER - TY - JOUR LB - 185. AU - Salim, A AU - Morton, CA TI - Comparison of photodynamic therapy with topical 5-fluorouracil in Bowen’s disease J2 - Br J Dermatol PY - 2000 VL - 143 SP - 114 ER - TY - JOUR LB - 186. AU - Basset-Seguin, N AU - Ibbotson, S AU - Emtestam, L AU - Tarstedt, M AU - Morton, C AU - Maroti, M TI - MAL-PDT versus cryotherapy for treatment of primary superficial basal cell carcinoma: Results of a five years prospective randomized trial J2 - J Invest Dermatol PY - 2006 VL - 126 SP - S34 ER - TY - JOUR LB - 187. AU - Basset-Seguin, N AU - Ibbotson, S AU - Emtestam, L AU - Tarstedt, M AU - Morton, C AU - Maroti, M TI - Methyl aminolaevulinate photodynamic therapy vs. cryotherapy in primary superficial basal cell carcinoma: results of a 36-month follow-up J2 - Br J Dermatol PY - 2005 VL - 153 SP - 29 ER - TY - JOUR LB - 188. AU - Basset-Seguin, N AU - Ibbotson, S AU - Emtestam, L AU - Tarstedt, M TI - MAL-PDT versus cryotherapy in primary superficial basal cell carcinoma. results of a 36-month follow-up J2 - J Am Acad Dermatol PY - 2005 VL - 52 SP - P162 ER - TY - JOUR LB - 189. AU - Basset-Seguin, N AU - Ibbotson, S AU - Emtestam, L AU - Tarstedt, M AU - Morton, C AU - Maroti, M TI - Photodynamic therapy using methyl aminolaevulinate is as efficacious as cryotherapy in basal cell carcinoma, with better cosmetic results J2 - Br J Dermatol PY - 2003 VL - 149 SP - 46 ER - TY - JOUR LB - 190. AU - Basset-Seguin, N AU - Ibbotson, S AU - Emtestam, L AU - Tarstedt, M AU - Morton, C AU - Maroti, M TI - Photodynamic therapy using topical methyl aminolaevulinate versus cryotherapy for treatment of primary superficial basal cell carcinoma: results of a five-year prospective randomized trial J2 - Br J Dermatol PY - 2006 VL - 155 SP - 57 ER - TY - JOUR LB - 191. AU - Berroeta, L AU - Clark, C AU - Dawe, RS AU - Ibbotson, SH AU - Fleming, CJ TI - Surgery versus debulking curettage plus topical photodynamic therapy for low-risk nodular basal cell carcinomas J2 - Br J Dermatol PY - 2005 VL - 153 SP - 79 ER - TY - JOUR LB - 192. AU - Rhodes, LE AU - De Rie, M AU - Enstrom, Y AU - Groves, R AU - Morken, T AU - Goulden, V TI - A randomized comparison of excision surgery and photodynamic therapy using methyl aminolaevulinate in nodular basal cell carcinoma J2 - Br J Dermatol PY - 2003 VL - 149 SP - 47 ER - TY - JOUR LB - 193. AU - Rhodes, LE AU - De Rie, M AU - Enstrom, Y AU - Groves, R AU - Morken, T AU - Goulden, V TI - A randomized European comparison of MAL-PDT and excision surgery in nodular basal cell carcinoma J2 - Br J Dermatol PY - 2005 VL - 153 SP - 28 EP - 29 ER - TY - JOUR LB - 194. AU - Rhodes, L AU - Groves, R AU - Wolf, P TI - A randomized European comparison of MAL-PDT and excision surgery in nodular basal cell carcinoma: a 24-month update J2 - J Am Acad Dermatol PY - 2005 VL - 52 SP - P158 ER - TY - JOUR LB - 195. AU - Rhodes, LE AU - de Rie, M AU - Enstrom, Y AU - Groves, R AU - Morken, T AU - Goulden, V TI - Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial J2 - Arch Dermatol PY - 2004 VL - 140 SP - 17 EP - 23 ER - TY - JOUR LB - 196. AU - Rhodes, L AU - de Rie, M AU - Enstrom, Y AU - Groves, R AU - Morken, T AU - Goulden, V TI - A randomized European comparison of excision surgery and MAL-PDT in nodular basal cell carcinoma: results from a 36-month follow-up [Abstract P08.69] J2 - J Eur Acad Dermatol Venereol PY - 2005 VL - 19 SP - 236 ER - TY - JOUR LB - 197. AU - Rhodes, LE AU - De Rie, M AU - Enstrom, Y AU - Groves, R AU - Morken, T AU - Goulden, V TI - A randomized European comparison of MAL-PDT and excision surgery in nodular basal cell carcinoma: results from a 60 month follow-up study J2 - J Invest Dermatol PY - 2006 VL - 126 SP - S34 ER - TY - JOUR LB - 198. AU - Hage, M AU - Van Dekken, H AU - Haringsma, J AU - Grool, TE AU - Steyerberg, EW AU - Van Veen, RLP TI - 5-aminolevulinic acid-based photodynamic therapy versus argon plasma coagulation for ablation of Barrett’s esophagus: a randomized trial J2 - Gastrointest Endosc PY - 2003 VL - 57 SP - A138 ER - TY - JOUR LB - 199. AU - Kelty, CJ AU - Ackroyd, R AU - Brown, NJ AU - Stephenson, TJ AU - Stoddard, CJ AU - Reed, MWR TI - Endoscopic ablation of Barrett’s oesophagus: a randomised trial of photodynamic therapy (PDT) versus argon plasma coagulation (APC) J2 - Gut PY - 2004 VL - 53 SP - 209 ER - TY - JOUR LB - 200. AU - Kelty, CJ AU - Ackroyd, R AU - Brown, NJ AU - Stephenson, TJ AU - Stoddard, CJ AU - Reed, MWR TI - Endoscopic ablation of Barrett’s esophagus: a randomized trial of photodynamic therapy (PDT) versus argon plasma coagulation (APC) J2 - Gastrointest Endosc PY - 2004 VL - 59 SP - A250 ER - TY - JOUR LB - 201. AU - Kelty, CJ AU - Ackroyd, R AU - Brown, NJ AU - Stephenson, TJ AU - Stoddard, CJ AU - Reed, MWR TI - Endoscopic ablation of Barrett’s oesophagus: a randomised controlled trial of photodynamic therapy vs. argon plasma coagulation J2 - Br J Surg PY - 2004 VL - 91 SP - 42 ER - TY - JOUR LB - 202. AU - Selvasekar, CR AU - Novelli, MR AU - Thorpe, S AU - Bown, SG AU - Lovat, LB TI - Interim results of a randomized controlled trial (RCT) comparing green and red laser photodynamic therapy using low dose ALA for high grade dysplasia in Barrett’s esophagus J2 - Gastrointest Endosc PY - 2004 VL - 59 SP - A252 ER - TY - JOUR LB - 203. AU - Mackenzie, G AU - Selvasekar, C AU - Clark, BR AU - Novelli, M AU - Thorpe, S AU - Mosse, C TI - Randomised controlled trial of photodynamic therapy using low dose 5 aminolevulinic acid activated by red or green light for high grade dysplasia in Barrett’s esophagus J2 - Gastroenterology PY - 2005 VL - 128 SP - A238 ER - TY - JOUR LB - 204. AU - Selvasekar, CR AU - Mackenzie, GD AU - Clark, BR AU - Novelli, MR AU - Thorpe, SM AU - Mosse, CA TI - Randomised controlled trial of photodynamic therapy using low dose 5 aminolevulinic acid activated by red or green light for high grade dysplasia in Barrett’s oesophagus J2 - Gut PY - 2005 VL - 54 SP - 206 ER - TY - JOUR LB - 205. AU - Mackenzie, GD AU - Selvasekar, CR AU - Jamieson, N AU - Mosse, CA AU - Thorpe, SM AU - Novelli, MR TI - Low incidence of oesophageal adenocarcinoma following optimal regimen of aminolaevulinic acid photofrin photodynamic therapy for high grade dysplasia in Barrett’s oesophagus J2 - Gut PY - 2007 VL - 56 SP - 25 ER - TY - JOUR LB - 206. AU - Overholt, BF AU - Lightdale, CJ AU - Wang, KK AU - Canto, MI AU - Burdick, S AU - Haggitt, RC TI - Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized phase III trial J2 - Gastrointest Endosc PY - 2005 VL - 62 SP - 488 EP - 498 ER - TY - JOUR LB - 207. AU - Overholt, BF AU - Lightdale, CJ AU - Wang, K AU - Canto, M AU - Burdick, S AU - Barr, H TI - International, multicenter, partially blinded, randomised study of the efficacy of photodymamic therapy (PDT) using porfimer sodium (POR) for the ablation of high-grade dysplasia (HGD) in Barrett’s esophagus (BE): results of 24-month follow-up J2 - Gastroenterology PY - 2003 VL - 124 SP - A20 ER - TY - JOUR LB - 208. AU - Bronner, MP AU - Overholt, BF AU - Taylor, SL AU - Haggitt, RC AU - Wang, KK AU - Burdick, JS TI - Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett’s esophagus with high-grade dysplasia J2 - Gastroenterology PY - 2009 VL - 136 SP - 56 EP - 64 ER - TY - JOUR LB - 209. AU - Bronner, M AU - Taylor, S AU - Overholt, B AU - Wang, K AU - Burdick, S AU - Lightdale, C TI - Squamous overgrowth in a 5-year randomized phase III trial of photodynamic therapy using porfirmer sodium in ablation of high-grade dysplasia in Barrett’s esophagus J2 - Gastroenterology PY - 2006 VL - 130 SP - A121 ER - TY - JOUR LB - 210. AU - Kapoor, N AU - Ragunath, K AU - Raman, V AU - Haqqani, M AU - Krasner, N TI - Endoscopic ablation of dysplastic Barrett’s oesophagus comparing argon plasma coagulation and photodynamic therapy: long term results of a randomised prospective trial J2 - Gut PY - 2005 VL - 54 SP - 126 ER - TY - JOUR LB - 211. AU - Maier, A AU - Anegg, U AU - Tomaselli, F AU - Rehak, P AU - Sankin, O AU - Fell, B TI - Does hyperbaric oxygen enhance the effect of photodynamic therapy in patients with advanced esophageal carcinoma? A clinical pilot study J2 - Endoscopy PY - 2000 VL - 32 SP - 42 EP - 48 ER - TY - CONF LB - 212. AU - Wieman, TJ TI - Photodynamic Therapy (PDT) with photofrin is effective in the palliation of obstructive endobronchial lung cancer: results of two randomized trials [Abstract 1782] T2 - Proceedings of the Annual Meeting of the American Association for Cancer Research [and] Annual Meeting of the American Society of Clinical Oncology CY - New Orleans, LA DA - 28 March–1 April 1998 ER - TY - JOUR LB - 213. AU - Vakulovskaya, EG AU - Ungiadze, GV AU - Tabolinovskaya, TD TI - Photodynamic therapy of oral cancer and cancer of oropharynx with second-generation photosensitizers J2 - Oral Oncol PY - 2005 VL - 1 IS - Suppl. SP - 68 ER -